Anti-HLAD/DR, DQ [35]
Invented by Prof Nancy Hogg from Cancer Research UK London Research Institute: Lincoln's Inn Fields
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151046 |
| Applications | FACS IHC IP |
| Antigen/Gene or Protein Targets | Human Leukocyte Antigen (HLA) D/DR, DQ (MHC Class II) |
| Reactivity | Human |
| Relevance | Human Leukocyte Antigens (HLA) are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). Clone 35 can be used for HLA typing, cytotoxic, binding and biochemical assays. |
| Host | Mouse |
| Subclass | IgG3 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Research Area | Immunology |
References: 2 entries
Allen et al. 1987. Cancer Res. 47(11):2919-23. PMID: 3105871.
Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes.
Europe PMC ID: 3105871
Add a reference
References: 2 entries
Allen et al. 1987. Cancer Res. 47(11):2919-23. PMID: 3105871.
Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes.
Add a reference
